-
1
-
-
0023082787
-
Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia
-
Javitt DC. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry. 1987;9:12-35.
-
(1987)
Hillside J Clin Psychiatry
, vol.9
, pp. 12-35
-
-
Javitt, D.C.1
-
2
-
-
0025952455
-
Recent advances in the phencyclidine model of schizophrenia
-
Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301-1308.
-
(1991)
Am J Psychiatry
, vol.148
, pp. 1301-1308
-
-
Javitt, D.C.1
Zukin, S.R.2
-
3
-
-
0028850552
-
Glutamate receptor dysfunction and schizophrenia
-
Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998-1007.
-
(1995)
Arch Gen Psychiatry
, vol.52
, pp. 998-1007
-
-
Olney, J.W.1
Farber, N.B.2
-
4
-
-
0030044715
-
The glutamatergic dysfunction hypothesis for schizophrenia
-
Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry. 1996;3:241-253.
-
(1996)
Harv Rev Psychiatry
, vol.3
, pp. 241-253
-
-
Coyle, J.T.1
-
5
-
-
65349120160
-
The dopamine hypothesis of schizophrenia: Version III-the final common pathway
-
Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull. 2009;35:549-562.
-
(2009)
Schizophr Bull
, vol.35
, pp. 549-562
-
-
Howes, O.D.1
Kapur, S.2
-
6
-
-
77955575322
-
Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists
-
Roberts BM, Seymour PA, Schmidt CJ, Williams GV, Castner SA. Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists. Psychopharmacology (Berl). 2010;210:407-418.
-
(2010)
Psychopharmacology (Berl)
, vol.210
, pp. 407-418
-
-
Roberts, B.M.1
Seymour, P.A.2
Schmidt, C.J.3
Williams, G.V.4
Castner, S.A.5
-
7
-
-
78650883892
-
Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride
-
Slifstein M, Suckow RF, Javitch JA, Cooper T, Lieberman J, Abi-Dargham A. Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride. J Cereb Blood Flow Metab. 2011;31:293-304.
-
(2011)
J Cereb Blood Flow Metab
, vol.31
, pp. 293-304
-
-
Slifstein, M.1
Suckow, R.F.2
Javitch, J.A.3
Cooper, T.4
Lieberman, J.5
Abi-Dargham, A.6
-
8
-
-
77956648156
-
N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
-
Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull. 2010;83:108-121.
-
(2010)
Brain Res Bull
, vol.83
, pp. 108-121
-
-
Kantrowitz, J.T.1
Javitt, D.C.2
-
9
-
-
9744231378
-
Neurodevelopment, neuroplasticity, and new genes for schizophrenia
-
Arnold SE, Talbot K, Hahn CG. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res. 2005;147:319-345.
-
(2005)
Prog Brain Res
, vol.147
, pp. 319-345
-
-
Arnold, S.E.1
Talbot, K.2
Hahn, C.G.3
-
10
-
-
78650006680
-
Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance
-
Karlsgodt KH, Robleto K, Trantham-Davidson H, et al. Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance. Biol Psychiatry. 2011;69:28-34.
-
(2011)
Biol Psychiatry
, vol.69
, pp. 28-34
-
-
Karlsgodt, K.H.1
Robleto, K.2
Trantham-Davidson, H.3
-
11
-
-
46249104490
-
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database
-
Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40:827-834.
-
(2008)
Nat Genet
, vol.40
, pp. 827-834
-
-
Allen, N.C.1
Bagade, S.2
McQueen, M.B.3
-
12
-
-
33846194535
-
Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis
-
Li D, He L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet Med. 2007;9:4-8.
-
(2007)
Genet Med
, vol.9
, pp. 4-8
-
-
Li, D.1
He, L.2
-
13
-
-
34447555923
-
Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia
-
Shinkai T, De Luca V, Hwang R, et al. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia. Neuromolecular Med. 2007;9:169-177.
-
(2007)
Neuromolecular Med
, vol.9
, pp. 169-177
-
-
Shinkai, T.1
De Luca, V.2
Hwang, R.3
-
14
-
-
34247863795
-
G72/G30 genes and schizophrenia: A systematic meta-analysis of association studies
-
Li D, He L. G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies. Genetics. 2007;175:917-922.
-
(2007)
Genetics
, vol.175
, pp. 917-922
-
-
Li, D.1
He, L.2
-
15
-
-
81355138985
-
Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder
-
Kulak A, Cuenod M, Do KQ. Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder. Behav Brain Res. 2012;226:563-570.
-
(2012)
Behav Brain Res
, vol.226
, pp. 563-570
-
-
Kulak, A.1
Cuenod, M.2
Do, K.Q.3
-
16
-
-
33745912772
-
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia
-
Hahn CG, Wang HY, Cho DS, et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med. 2006;12:824-828.
-
(2006)
Nat Med
, vol.12
, pp. 824-828
-
-
Hahn, C.G.1
Wang, H.Y.2
Cho, D.S.3
-
17
-
-
77649197534
-
Increased synaptic dopamine function in associative regions of the striatum in schizophrenia
-
Kegeles LS, Abi-Dargham A, Frankle WG, et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry. 2010;67:231-239.
-
(2010)
Arch Gen Psychiatry
, vol.67
, pp. 231-239
-
-
Kegeles, L.S.1
Abi-Dargham, A.2
Frankle, W.G.3
-
18
-
-
58149489347
-
Elevated striatal dopamine function linked to prodromal signs of schizophrenia
-
Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009;66:13-20.
-
(2009)
Arch Gen Psychiatry
, vol.66
, pp. 13-20
-
-
Howes, O.D.1
Montgomery, A.J.2
Asselin, M.C.3
-
19
-
-
26844447871
-
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man
-
Aalto S, Ihalainen J, Hirvonen J, et al. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl). 2005;182:375-383.
-
(2005)
Psychopharmacology (Berl)
, vol.182
, pp. 375-383
-
-
Aalto, S.1
Ihalainen, J.2
Hirvonen, J.3
-
20
-
-
0037209259
-
Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release
-
Balla A, Sershen H, Serra M, Koneru R, Javitt DC. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release. Neuropsychopharmacology. 2003;28:34-44.
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 34-44
-
-
Balla, A.1
Sershen, H.2
Serra, M.3
Koneru, R.4
Javitt, D.C.5
-
21
-
-
0842286593
-
Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists
-
Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists. Neuropsychopharmacology. 2004;29:300-307.
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 300-307
-
-
Javitt, D.C.1
Balla, A.2
Burch, S.3
Suckow, R.4
Xie, S.5
Sershen, H.6
-
22
-
-
36849089633
-
Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: Implications in NMDA/glycine-site- mediated dopaminergic dysregulation and dopamine transporter function
-
Sershen H, Balla A, Aspromonte JM, Xie S, Cooper TB, Javitt DC. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function. Neurochem Int. 2008;52:119-129.
-
(2008)
Neurochem Int
, vol.52
, pp. 119-129
-
-
Sershen, H.1
Balla, A.2
Aspromonte, J.M.3
Xie, S.4
Cooper, T.B.5
Javitt, D.C.6
-
23
-
-
84870717591
-
Effects of novel high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia
-
[published online ahead of print May 09,2012] doi:10.1016/j. euroneuro.2012.03.006
-
Balla A, Schneider S, Sershen H, Javitt DC. Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia [published online ahead of print May 09, 2012]. Eur Neuropsychopharmacol. doi:10.1016/j. euroneuro.2012.03.006.
-
Eur Neuropsychopharmacol
-
-
Balla, A.1
Schneider, S.2
Sershen, H.3
Javitt, D.C.4
-
24
-
-
69849109615
-
Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia
-
Schobel SA, Kelly MA, Corcoran CM, et al. Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia. Schizophr Res. 2009;114:110-118.
-
(2009)
Schizophr Res
, vol.114
, pp. 110-118
-
-
Schobel, S.A.1
Kelly, M.A.2
Corcoran, C.M.3
-
25
-
-
73949124536
-
Sensory processing in schizophrenia: Neither simple nor intact
-
Javitt DC. Sensory processing in schizophrenia: neither simple nor intact. Schizophr Bull. 2009;35:1059-1064.
-
(2009)
Schizophr Bull
, vol.35
, pp. 1059-1064
-
-
Javitt, D.C.1
-
26
-
-
0029859204
-
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: Implications for schizophrenia
-
Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA. 1996;93:11962-11967.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 11962-11967
-
-
Javitt, D.C.1
Steinschneider, M.2
Schroeder, C.E.3
Arezzo, J.C.4
-
27
-
-
80053221118
-
Translating glutamate: From pathophysiology to treatment
-
Javitt DC, Schoepp D, Kalivas PW, et al.Translating glutamate: from pathophysiology to treatment. Sci Transl Med. 2011;3:102mr102.
-
(2011)
Sci Transl Med
, vol.3
, pp. 102-102
-
-
Javitt, D.C.1
Schoepp, D.2
Kalivas, P.W.3
-
28
-
-
0037209132
-
Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: Implications for the neuropharmacology of cognitive deficits in schizophrenia
-
Umbricht D, Vollenweider FX, Schmid L, et al. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology. 2003;28:170-181.
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 170-181
-
-
Umbricht, D.1
Vollenweider, F.X.2
Schmid, L.3
-
29
-
-
46149109833
-
Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
-
Heekeren K, Daumann J, Neukirch A, et al. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology (Berl). 2008;199:77-88.
-
(2008)
Psychopharmacology (Berl)
, vol.199
, pp. 77-88
-
-
Heekeren, K.1
Daumann, J.2
Neukirch, A.3
-
31
-
-
34247165744
-
Effects of NMDA receptor antagonist memantine on mismatch negativity
-
Korostenskaja M, Nikulin VV, Kicic D, Nikulina AV, Kähkönen S. Effects of NMDA receptor antagonist memantine on mismatch negativity. Brain Res Bull. 2007;72:275-283.
-
(2007)
Brain Res Bull
, vol.72
, pp. 275-283
-
-
Korostenskaja, M.1
Nikulin, V.V.2
Kicic, D.3
Nikulina, A.V.4
Kähkönen, S.5
-
32
-
-
77952554458
-
Dose-related effects of memantine on a mismatch negativity-like response in anesthetized rats
-
Tikhonravov D, Neuvonen T, Pertovaara A, et al. Dose-related effects of memantine on a mismatch negativity-like response in anesthetized rats. Neuroscience. 2010;167:1175-1182.
-
(2010)
Neuroscience
, vol.167
, pp. 1175-1182
-
-
Tikhonravov, D.1
Neuvonen, T.2
Pertovaara, A.3
-
33
-
-
0036501435
-
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers
-
Umbricht D, Koller R, Vollenweider FX, Schmid L. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry. 2002;51:400-406.
-
(2002)
Biol Psychiatry
, vol.51
, pp. 400-406
-
-
Umbricht, D.1
Koller, R.2
Vollenweider, F.X.3
Schmid, L.4
-
34
-
-
79955481536
-
Prediction of psychosis by mismatch negativity
-
Bodatsch M, Ruhrmann S, Wagner M, et al. Prediction of psychosis by mismatch negativity. Biol Psychiatry. 2011;69:959-966.
-
(2011)
Biol Psychiatry
, vol.69
, pp. 959-966
-
-
Bodatsch, M.1
Ruhrmann, S.2
Wagner, M.3
-
35
-
-
75749085177
-
Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine
-
Hong LE, Summerfelt A, Buchanan RW, et al. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology. 2010;35:632-640.
-
(2010)
Neuropsychopharmacology
, vol.35
, pp. 632-640
-
-
Hong, L.E.1
Summerfelt, A.2
Buchanan, R.W.3
-
36
-
-
69249209812
-
Neurophysiological and neurochemical animal models of schizophrenia: Focus on glutamate
-
Bickel S, Javitt DC. Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate. Behav Brain Res. 2009;204:352-362.
-
(2009)
Behav Brain Res
, vol.204
, pp. 352-362
-
-
Bickel, S.1
Javitt, D.C.2
-
37
-
-
18244366892
-
Early-stage visual processing and cortical amplification deficits in schizophrenia
-
Butler PD, Zemon V, Schechter I, et al. Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch Gen Psychiatry. 2005;62:495-504.
-
(2005)
Arch Gen Psychiatry
, vol.62
, pp. 495-504
-
-
Butler, P.D.1
Zemon, V.2
Schechter, I.3
-
38
-
-
67650130341
-
When doors of perception close: Bottom-up models of disrupted cognition in schizophrenia
-
Javitt DC. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol. 2009;5:249-275.
-
(2009)
Annu Rev Clin Psychol
, vol.5
, pp. 249-275
-
-
Javitt, D.C.1
-
39
-
-
84861562756
-
Consequences of magnocellular dysfunction on processing attended information in schizophrenia
-
Martínez A, Hillyard SA, Bickel S, Dias EC, Butler PD, Javitt DC. Consequences of magnocellular dysfunction on processing attended information in schizophrenia. Cereb Cortex. 2012;22:1282-1293.
-
(2012)
Cereb Cortex
, vol.22
, pp. 1282-1293
-
-
Martínez, A.1
Hillyard, S.A.2
Bickel, S.3
Dias, E.C.4
Butler, P.D.5
Javitt, D.C.6
-
40
-
-
77955878074
-
Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: An integrated neuroimaging study
-
Sehatpour P, Dias EC, Butler PD, et al. Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: an integrated neuroimaging study. Arch Gen Psychiatry. 2010;67:772-782.
-
(2010)
Arch Gen Psychiatry
, vol.67
, pp. 772-782
-
-
Sehatpour, P.1
Dias, E.C.2
Butler, P.D.3
-
41
-
-
79960321156
-
Early sensory contributions to contextual encoding deficits in schizophrenia
-
Dias EC, Butler PD, Hoptman MJ, Javitt DC. Early sensory contributions to contextual encoding deficits in schizophrenia. Arch Gen Psychiatry. 2011;68:654-664.
-
(2011)
Arch Gen Psychiatry
, vol.68
, pp. 654-664
-
-
Dias, E.C.1
Butler, P.D.2
Hoptman, M.J.3
Javitt, D.C.4
-
42
-
-
84871845819
-
Reduction in tonal discriminations predicts receptive emotion processing deficits in schizophrenia and schizoaffective disorder
-
[published online ahead of print July 05 2011] doi:10.1093/schbul/sbr060
-
Kantrowitz JT, Leitman DI, Lehrfeld JM, et al. Reduction in tonal discriminations predicts receptive emotion processing deficits in schizophrenia and schizoaffective disorder [published online ahead of print July 05, 2011]. Schizophr Bull. doi:10.1093/schbul/sbr060.
-
Schizophr Bull
-
-
Kantrowitz, J.T.1
Leitman, D.I.2
Lehrfeld, J.M.3
-
43
-
-
73949149661
-
Sensory contributions to impaired emotion processing in schizophrenia
-
Butler PD, Abeles IY, Weiskopf NG, et al. Sensory contributions to impaired emotion processing in schizophrenia. Schizophr Bull. 2009;35:1095-1107.
-
(2009)
Schizophr Bull
, vol.35
, pp. 1095-1107
-
-
Butler, P.D.1
Abeles, I.Y.2
Weiskopf, N.G.3
-
44
-
-
67349149048
-
Association of impaired facial affect recognition with basic facial and visual processing deficits in schizophrenia
-
Norton D, McBain R, Holt DJ, Ongur D, Chen Y. Association of impaired facial affect recognition with basic facial and visual processing deficits in schizophrenia. Biol Psychiatry. 2009;65:1094-1098.
-
(2009)
Biol Psychiatry
, vol.65
, pp. 1094-1098
-
-
Norton, D.1
McBain, R.2
Holt, D.J.3
Ongur, D.4
Chen, Y.5
-
45
-
-
80051799656
-
Ketamine effects on brain function-simultaneous fMRI/EEG during a visual oddball task
-
Musso F, Brinkmeyer J, Ecker D, et al. Ketamine effects on brain function-simultaneous fMRI/EEG during a visual oddball task. Neuroimage. 2011;58:508-525.
-
(2011)
Neuroimage
, vol.58
, pp. 508-525
-
-
Musso, F.1
Brinkmeyer, J.2
Ecker, D.3
-
46
-
-
77953206219
-
Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: Implications for pathophysiology of executive dysfunction in schizophrenia
-
Wylie GR, Clark EA, Butler PD, Javitt DC. Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: implications for pathophysiology of executive dysfunction in schizophrenia. Schizophr Bull. 2010;36:585-594.
-
(2010)
Schizophr Bull
, vol.36
, pp. 585-594
-
-
Wylie, G.R.1
Clark, E.A.2
Butler, P.D.3
Javitt, D.C.4
-
47
-
-
34247568367
-
Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine
-
Linn GS, O'Keeffe RT, Lifshitz K, Schroeder C, Javitt DC. Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine. Psychopharmacology (Berl). 2007;192:27-38.
-
(2007)
Psychopharmacology (Berl)
, vol.192
, pp. 27-38
-
-
Linn, G.S.1
O'Keeffe, R.T.2
Lifshitz, K.3
Schroeder, C.4
Javitt, D.C.5
-
48
-
-
79952454124
-
Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis
-
Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J. Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2011;231:86-91.
-
(2011)
J Neuroimmunol
, vol.231
, pp. 86-91
-
-
Wandinger, K.P.1
Saschenbrecker, S.2
Stoecker, W.3
Dalmau, J.4
-
49
-
-
84856104234
-
Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia
-
Powell SB, Sejnowski TJ, Behrens MM. Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology. 2012;62:1322-1331.
-
(2012)
Neuropharmacology
, vol.62
, pp. 1322-1331
-
-
Powell, S.B.1
Sejnowski, T.J.2
Behrens, M.M.3
-
50
-
-
0023091647
-
Glycine potentiates the NMDA response in cultured mouse brain neurons
-
Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987;325:529-531.
-
(1987)
Nature
, vol.325
, pp. 529-531
-
-
Johnson, J.W.1
Ascher, P.2
-
51
-
-
0028988978
-
D-serine, an endogenous synaptic modulator: Localization to astrocytes and glutamate-stimulated release
-
Schell MJ, Molliver ME, Snyder SH. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA. 1995;92:3948-3952.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 3948-3952
-
-
Schell, M.J.1
Molliver, M.E.2
Snyder, S.H.3
-
52
-
-
48749112603
-
N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial
-
Berk M, Copolov D, Dean O, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008;64:361-368.
-
(2008)
Biol Psychiatry
, vol.64
, pp. 361-368
-
-
Berk, M.1
Copolov, D.2
Dean, O.3
-
53
-
-
36849071470
-
Sarcosine (N-methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
-
Lane HY, Liu YC, Huang CL, et al. Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study. Biol Psychiatry. 2008; 63:9-12.
-
(2008)
Biol Psychiatry
, vol.63
, pp. 9-12
-
-
Lane, H.Y.1
Liu, Y.C.2
Huang, C.L.3
-
54
-
-
67649989298
-
Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modification
-
Javitt DC. Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification. Curr Opin Drug Discov Devel. 2009;12:468-478.
-
(2009)
Curr Opin Drug Discov Devel
, vol.12
, pp. 468-478
-
-
Javitt, D.C.1
-
55
-
-
9244243064
-
Glutamatergic drugs for schizophrenia: A systematic review and meta-analysis
-
Tuominen HJ, Tiihonen J, Wahlbeck K. Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2005;72:225-234.
-
(2005)
Schizophr Res
, vol.72
, pp. 225-234
-
-
Tuominen, H.J.1
Tiihonen, J.2
Wahlbeck, K.3
-
56
-
-
77949447469
-
Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis
-
Tsai GE, Lin PY. Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr Pharm Des. 2010;16:522-537.
-
(2010)
Curr Pharm des
, vol.16
, pp. 522-537
-
-
Tsai, G.E.1
Lin, P.Y.2
-
57
-
-
80052996482
-
Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia
-
Singh SP, Singh V. Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia. CNS Drugs. 2011;25:859-885.
-
(2011)
CNS Drugs
, vol.25
, pp. 859-885
-
-
Singh, S.P.1
Singh, V.2
-
58
-
-
84861996250
-
D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease
-
Gelfin E, Kaufman Y, Korn-Lubetzki I, et al. D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease. Int J Neuropsychopharmacol. 2011:1-7.
-
(2011)
Int J Neuropsychopharmacol
, pp. 1-7
-
-
Gelfin, E.1
Kaufman, Y.2
Korn-Lubetzki, I.3
-
59
-
-
0030811293
-
Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide
-
Javitt DC, Sershen H, Hashim A, Lajtha A. Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide. Neuropsychopharmacology. 1997;17:202-204.
-
(1997)
Neuropsychopharmacology
, vol.17
, pp. 202-204
-
-
Javitt, D.C.1
Sershen, H.2
Hashim, A.3
Lajtha, A.4
-
60
-
-
0033558578
-
Bennett research award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors
-
Javitt DC, Balla A, Sershen H, Lajtha A. A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors. Biol Psychiatry. 1999;45:668-679.
-
(1999)
Biol Psychiatry
, vol.45
, pp. 668-679
-
-
Javitt, D.C.1
Balla, A.2
Sershen, H.3
Lajtha, A.A.E.4
-
61
-
-
0034015991
-
Inhibition of striatal dopamine release by glycine and glycyldodecylamide
-
Javitt DC, Sershen H, Hashim A, Lajtha A. Inhibition of striatal dopamine release by glycine and glycyldodecylamide. Brain Res Bull. 2000;52:213-216.
-
(2000)
Brain Res Bull
, vol.52
, pp. 213-216
-
-
Javitt, D.C.1
Sershen, H.2
Hashim, A.3
Lajtha, A.4
-
62
-
-
77949431787
-
Glycine transporter inhibition reverses ketamine-induced working memory deficits
-
Roberts BM, Shaffer CL, Seymour PA, Schmidt CJ, Williams GV, Castner SA. Glycine transporter inhibition reverses ketamine-induced working memory deficits. Neuroreport. 2010;21:390-394.
-
(2010)
Neuroreport
, vol.21
, pp. 390-394
-
-
Roberts, B.M.1
Shaffer, C.L.2
Seymour, P.A.3
Schmidt, C.J.4
Williams, G.V.5
Castner, S.A.6
-
63
-
-
77953771657
-
Selective GlyT1 inhibitors: Discovery of [4-(3-fluoro-5- trifluoromethylpyridin-2-yl) piperazin-1-yl][5-methanesulfon yl-2-((S)-2 2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia
-
Pinard E, Alanine A, Alberati D, et al. Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl) piperazin-1-yl][5- methanesulfon yl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia. J Med Chem. 2010;53:4603-4614.
-
(2010)
J Med Chem
, vol.53
, pp. 4603-4614
-
-
Pinard, E.1
Alanine, A.2
Alberati, D.3
-
64
-
-
79955730287
-
Glycine transporter type 1 (GLYT1) inhibitor RG1678: Positive results of the proof-of-concept study for the treatment of negative symptoms in schizophrenia
-
Umbricht D, Yoo K, Youssef E, et al. Glycine transporter type 1 (GLYT1) inhibitor RG1678: positive results of the proof-of-concept study for the treatment of negative symptoms in schizophrenia. Neuropsychopharmacol. 2010;35:s320-321.
-
(2010)
Neuropsychopharmacol
, vol.35
-
-
Umbricht, D.1
Yoo, K.2
Youssef, E.3
-
65
-
-
67349116852
-
Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine
-
Hashimoto K, Fujita Y, Horio M, et al. Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol Psychiatry. 2009;65:1103-1106.
-
(2009)
Biol Psychiatry
, vol.65
, pp. 1103-1106
-
-
Hashimoto, K.1
Fujita, Y.2
Horio, M.3
-
66
-
-
0037150760
-
A novel alanine-insensitive D-serine transporter in rat brain synaptosomal membranes
-
Javitt DC, Balla A, Sershen H. A novel alanine-insensitive D-serine transporter in rat brain synaptosomal membranes. Brain Res. 2002;941:146-149.
-
(2002)
Brain Res
, vol.941
, pp. 146-149
-
-
Javitt, D.C.1
Balla, A.2
Sershen, H.3
-
67
-
-
47249165587
-
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients
-
Lavoie S, Murray MM, Deppen P, et al. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology. 2008;33:2187-2199.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 2187-2199
-
-
Lavoie, S.1
Murray, M.M.2
Deppen, P.3
-
68
-
-
36848999415
-
Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia
-
Roffman JL, Weiss AP, Purcell S, et al. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol Psychiatry. 2008;63:42-48.
-
(2008)
Biol Psychiatry
, vol.63
, pp. 42-48
-
-
Roffman, J.L.1
Weiss, A.P.2
Purcell, S.3
-
69
-
-
77749242786
-
Cortical kynurenine pathway metabolism: A novel target for cognitive enhancement in Schizophrenia
-
Wonodi I Schwarcz R. Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia. Schizophr Bull. 2010;36:211-218.
-
(2010)
Schizophr Bull
, vol.36
, pp. 211-218
-
-
Wonodi, I.1
Schwarcz, R.2
-
70
-
-
52449083063
-
[11C] CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: A PET study in conscious monkeys
-
Hashimoto K, Nishiyama S, Ohba H, et al. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys. PLoS ONE. 2008;3:e3231.
-
(2008)
PLoS ONE
, vol.3
-
-
Hashimoto, K.1
Nishiyama, S.2
Ohba, H.3
-
71
-
-
63049128572
-
GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum
-
Balla A, Nattini ME, Sershen H, Lajtha A, Dunlop DS, Javitt DC. GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology. 2009;56:915-921.
-
(2009)
Neuropharmacology
, vol.56
, pp. 915-921
-
-
Balla, A.1
Nattini, M.E.2
Sershen, H.3
Lajtha, A.4
Dunlop, D.S.5
Javitt, D.C.6
-
72
-
-
77954145611
-
The importance of a good night's sleep: An open-label trial of the sodium salt of gamma-hydroxybutyric acid in insomnia associated with schizophrenia
-
Kantrowitz JT, Oakman E, Bickel S, et al. The importance of a good night's sleep: an open-label trial of the sodium salt of gamma-hydroxybutyric acid in insomnia associated with schizophrenia. Schizophr Res. 2010;120:225-226.
-
(2010)
Schizophr Res
, vol.120
, pp. 225-226
-
-
Kantrowitz, J.T.1
Oakman, E.2
Bickel, S.3
-
73
-
-
34047185321
-
The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents
-
Leitman DI, Hoptman MJ, Foxe JJ, et al. The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents. Am J Psychiatry. 2007;164:474-482.
-
(2007)
Am J Psychiatry
, vol.164
, pp. 474-482
-
-
Leitman, D.I.1
Hoptman, M.J.2
Foxe, J.J.3
-
74
-
-
0032925438
-
Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
-
Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry. 1999;56:29-36.
-
(1999)
Arch Gen Psychiatry
, vol.56
, pp. 29-36
-
-
Heresco-Levy, U.1
Javitt, D.C.2
Ermilov, M.3
Mordel, C.4
Silipo, G.5
Lichtenstein, M.6
-
75
-
-
1442333154
-
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
-
Heresco-Levy U. High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biol Psychiatr. 2004;55:165-171.
-
(2004)
Biol Psychiatr
, vol.55
, pp. 165-171
-
-
Heresco-Levy, U.1
-
76
-
-
15444377601
-
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
-
Heresco-Levy U, Javitt DC, Ebstein R, et al. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry. 2005;57:577-585.
-
(2005)
Biol Psychiatry
, vol.57
, pp. 577-585
-
-
Heresco-Levy, U.1
Javitt, D.C.2
Ebstein, R.3
|